Get notified when CELU files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: CELU Celularity Inc 10-K/A

Celularity files 10-K/A to add missing Part III governance disclosures; no change to financial results

Filed October 20, 2026 · Period ending December 31, 2025 · Compared to 10-K Apr 30, 2026 · ~1 min read

Key Financials

SEC XBRL

Period financials are unchanged from the original 10-K (same period end Dec 31, 2025). This amendment updates disclosure only — see the diff below.

Key Changes

  • medium

    The amendment adds Part III disclosures (directors, executive officers, compensation, security ownership) that were omitted from the original April 2026 10-K.

    Amendment Purpose view on EDGAR →
  • medium

    The filing explicitly states it does not update financial statements, risk factors, MD&A, or any other disclosures from the original 10-K.

    Scope Limitation view on EDGAR →
  • low

    New CEO and CFO certifications under Sarbanes-Oxley are included as exhibits, standard for a 10-K/A adding Part III information.

    New Certifications verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (DPZ 10-Q) is open in full — no account needed.

Partner

Trade CELU commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Oct 20, 2026 · How we verify